Dr. Hönle AG

HNL

DE0005157101

Industrial Machinery & Equipment

Real-time Estimate Tradegate Other stock markets 08:47:34 2024-05-31 am EDT			5-day change	1st Jan Change
19.82 ^EUR	-0.63%		-1.74%	+12.86%

May. 08	Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
Feb. 26	Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

DR HOENLE AG : Warburg Research reiterates its Buy rating

April 14, 2020 at 05:35 am EDT

In a research note published by Malte Schaumann, Warburg Research advises its customers to buy the stock. The target price is lowered from EUR 72 to EUR 65.

Latest news about Dr. Hönle AG

Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 07	CI
Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 26	CI
Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2023	Jan. 24	CI
Dr. Hönle Ag Provides Earnings Guidance for the Year 2022/2023 and 2023/2024	Dec. 05	CI
Dr. Hönle AG Announces Management Changes	23-10-20	CI
Dr. Hönle AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-07	CI
Dr. Hönle Ag Provides Earnings Guidance for the Year 2023	23-08-07	CI
Dr. Hönle AG Revises Earnings Guidance for the Year 2022/ 2023	23-06-01	CI
Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-12	CI
Dr. Hönle AG Announces Executive Changes	23-04-25	CI
Dr. Hönle AG Announces Board Changes	23-03-31	CI
Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-24	CI
Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2022	23-01-30	CI
Dr. Hönle AG Announces Planned Change in Supervisory Board	22-12-15	CI
An unknown buyer acquired Raesch Quarz GmbH from Dr. Hönle AG.	22-12-11	CI
Dr. Hönle AG Revises Earnings Guidance for the Year 2021/2022	22-11-02	CI
Dr. Hönle AG(XTRA:HNL) dropped from S&P Global BMI Index	22-09-19	CI
Norbert Haimerl Becomes CEO of Dr. Hönle AG	22-08-23	CI
Dr. Hönle AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-05	CI
Dr. Hönle AG Provides Earnings Guidance for 2022	22-07-29	CI
Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-05-12	CI
Dr. Hönle Ag Provides Earnings Guidance for 2022	22-05-12	CI
Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2021	22-02-22	CI
Dr. Hönle AG Provides Earnings Guidance for the Financial Year 2021/2022	22-02-18	CI
Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2021	22-01-27	CI

Dr Hoenle AG is a Germany-based company engaged in the basic materials and industrials sectors. The Company develops, manufactures and supplies ultraviolet (UV) equipment. The Company operates three business segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment encompasses the development, production and sale of UV equipment and systems used for drying inks and coatings, for curing adhesives and plastics, disinfecting surfaces and for sunlight simulation. The Adhesives segment comprises the development, production and sale of UV industrial adhesives for the use in the automotive, electronics, medical technology and optics industries, among others. The Glass and Lamps segment includes the development, production and sale of tubing and semi-finished goods made from quartz glass as well as the manufacture of UV medium-pressure and low-pressure lamps. The Company is globally active, with over 69 locations in 27 countries.

Sector

Industrial Machinery & Equipment

Calendar

2024-08-06 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Dr. Hönle AG

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

19.95 EUR

Average target price

25.2 EUR

Spread / Average Target

+26.32%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Industrial Machinery & Equipment

	1st Jan change	Capi.
DR. HÖNLE AG	+12.86%	131M
ATLAS COPCO AB	+15.76%	87.27B
PARKER-HANNIFIN CORPORATION	+13.84%	67.41B
INGERSOLL RAND INC.	+18.96%	37.12B
XYLEM INC.	+21.90%	33.8B
SANDVIK AB	+5.82%	27.3B
FANUC CORPORATION	+6.08%	26.81B
FORTIVE CORPORATION	-0.07%	25.9B
DOVER CORPORATION	+18.09%	24.96B
TECHTRONIC INDUSTRIES CO. LTD.	+2.85%	22.38B

Other Industrial Machinery & Equipment

Dr. Hönle AG

Equities

HNL

DE0005157101

Industrial Machinery & Equipment

DR HOENLE AG : Warburg Research reiterates its Buy rating

Latest news about Dr. Hönle AG

Chart Dr. Hönle AG

Company Profile

Income Statement Evolution

Ratings for Dr. Hönle AG

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Industrial Machinery & Equipment